Cite
HARVARD Citation
Schaffer, M. et al. (2020). Activity of ibrutinib plus R-CHOP in diffuse large B-cell lymphoma: Response, pharmacodynamic, and biomarker analyses of a phase Ib study. Cancer treatment and research communications. p. . [Online].